SteriWeb Medical Gets FDA OTC Clearance for Omnicide Antimicrobial Gel

SteriWeb Medical has reported FDA over the counter clearance for Omnicide Antimicrobial Gel.

According to a release from the company, laboratory data has also demonstrated complete effectiveness against pathogenic fungi, molds, and yeasts, rendering Omnicide an appropriate choice for a variety of clinical conditions and an ideal addition to any topical infection treatment protocol. Omnicide's combination of antimicrobial ingredients differentiates it from topical antibiotics, which have become far less clinically effective as pathogenic bacteria, such as MRSA, have developed, and continue to develop, resistance over time.

SteriWeb Founder and Chief Operating Officer Bradley Burnam states: "In light of the recent World Health Organization's landmark report on antibiotic resistance, it is clear that currently available topical infection treatments are becoming less and less effective. Omnicide is a timely and important innovation."

More information and complete details:

www.steriwebrx.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))